UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Repurchase Intention in Online Knowledge Service: The Brand Awareness Perspective Journal article
Du, Helen S., Xu, Jiahong, Tang, Heng, Jiang, Ruixin. Repurchase Intention in Online Knowledge Service: The Brand Awareness Perspective[J]. Journal of Computer Information Systems, 2022, 62(1), 174-185.
Authors:  Du, Helen S.;  Xu, Jiahong;  Tang, Heng;  Jiang, Ruixin
Favorite | TC[WOS]:7 TC[Scopus]:15  IF:2.5/3.1 | Submit date:2022/05/17
Brand Awareness  Expectation-confirmation Theory  Is Success Model  Repurchase Intention  Switching Barrier  
Automatic range adjustment of the fluorescence immunochromatographic assay based on image processing Journal article
Jiang,Ruixin, Wu,Huihuang, Yang,Jianpeng, Jiang,Haiyan, Du,Min, Vai,Mangi, Pun,Siohang, Gao,Yueming. Automatic range adjustment of the fluorescence immunochromatographic assay based on image processing[J]. SENSORS, 2019, 20(1), 209.
Authors:  Jiang,Ruixin;  Wu,Huihuang;  Yang,Jianpeng;  Jiang,Haiyan;  Du,Min; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:3.4/3.7 | Submit date:2021/03/11
Fluorescence Immunochromatographic Assay  Point-of-care Testing  Automatic Range Adjustment  Image Processing  Exposure Time  
TNFR2-expressing CD4(+) Foxp3(+) regulatory T cells in cancer immunology and immunotherapy Book chapter
出自: Progress in Molecular Biology and Translational Science, CA:Elsevier, 2019, 页码:101-117
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite | TC[WOS]:16 TC[Scopus]:16 | Submit date:2019/05/08
Regulatory t Cells  Tumor Necrosis Factor  Tumor Necrosis Factor Receptor Type 2  Cancer  Immunotherapy  
TNFR2 and Regulatory T Cells: Potential Immune Checkpoint Target in Cancer Immunotherapy Book chapter
出自: Progress in Molecular Biology and Translational Science:ELSEVIER ACADEMIC PRESS INC, 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA, 2019, 页码:101-117
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite | TC[WOS]:16 TC[Scopus]:16 | Submit date:2020/05/05
Regulatory t Cells  Tumor Necrosis Factor Receptor Type 2  Cancer  Immunotherapy  Tumor Necrosis Factor